Cargando…
New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review
Although current therapies can be successful at suppressing hepatitis B viral load, long-term viral cure is not within reach. Subsequent strategies combining pegylated interferon alfa with nucleoside/nucleotide analogues have not resulted in any major paradigm shift. An improved understanding of the...
Autores principales: | Arends, Joop E., Lieveld, Faydra I., Ahmad, Shazaad, Ustianowski, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700893/ https://www.ncbi.nlm.nih.gov/pubmed/29071665 http://dx.doi.org/10.1007/s40121-017-0173-y |
Ejemplares similares
-
Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy
por: van Welzen, Berend J, et al.
Publicado: (2020) -
Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use
por: Ustianowski, Andrew, et al.
Publicado: (2015) -
The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study
por: Kracht, Patricia A. M., et al.
Publicado: (2018) -
Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020) -
Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)